Caprion Announces Biomarker Discovery Collaboration with Vertex
News Mar 30, 2006
The collaboration will use Caprion's CellCarta® proteomics platform to support clinical biomarker discovery.
Caprion will identify potential pharmacodynamic biomarkers in samples from certain clinical and pre-clinical studies conducted by Vertex.
"Caprion is looking forward to working with Vertex on this clinical biomarker discovery collaboration," noted Dr. Daniel Chelsky, Chief Scientific Officer at Caprion.
"We believe that Caprion's capabilities in the discovery of protein biomarkers may significantly impact development efforts for one or more Vertex compounds."
8th Edition of International Conference and Exhibition on Separation Techniques
Jul 29 - Jul 30, 2019